DK0656015T3 - Nye inklusionskomplekser af nimesulidsalt med cyclodextrin - Google Patents

Nye inklusionskomplekser af nimesulidsalt med cyclodextrin

Info

Publication number
DK0656015T3
DK0656015T3 DK94919796T DK94919796T DK0656015T3 DK 0656015 T3 DK0656015 T3 DK 0656015T3 DK 94919796 T DK94919796 T DK 94919796T DK 94919796 T DK94919796 T DK 94919796T DK 0656015 T3 DK0656015 T3 DK 0656015T3
Authority
DK
Denmark
Prior art keywords
pct
cyclodextrin
inclusion complexes
complexes
novel inclusion
Prior art date
Application number
DK94919796T
Other languages
Danish (da)
English (en)
Inventor
Joseph Geczy
Original Assignee
Europharmaceuticals Sa
Cyclolab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europharmaceuticals Sa, Cyclolab Ltd filed Critical Europharmaceuticals Sa
Application granted granted Critical
Publication of DK0656015T3 publication Critical patent/DK0656015T3/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94919796T 1993-05-24 1994-05-18 Nye inklusionskomplekser af nimesulidsalt med cyclodextrin DK0656015T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9301518A HU210922B (en) 1993-05-24 1993-05-24 Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
PCT/HU1994/000014 WO1994028031A1 (en) 1993-05-24 1994-05-18 New nimesulide salt cyclodextrin inclusion complexes

Publications (1)

Publication Number Publication Date
DK0656015T3 true DK0656015T3 (da) 1999-05-25

Family

ID=10983630

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919796T DK0656015T3 (da) 1993-05-24 1994-05-18 Nye inklusionskomplekser af nimesulidsalt med cyclodextrin

Country Status (17)

Country Link
US (1) US5744165A (cs)
EP (1) EP0656015B1 (cs)
JP (1) JPH07509498A (cs)
KR (1) KR950702580A (cs)
AT (1) ATE170194T1 (cs)
AU (1) AU675146B2 (cs)
CA (1) CA2140887C (cs)
CZ (1) CZ285962B6 (cs)
DE (1) DE69412760T2 (cs)
DK (1) DK0656015T3 (cs)
ES (1) ES2124893T3 (cs)
FI (1) FI950294A0 (cs)
HU (1) HU210922B (cs)
NO (1) NO307570B1 (cs)
RU (1) RU2129564C1 (cs)
SI (1) SI0656015T1 (cs)
WO (1) WO1994028031A1 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960700361A (ko) * 1993-02-19 1996-01-20 우에하라 아키라 5-아미노아세틸아미노술폰아닐리드 화합물
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
UA57734C2 (uk) 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
IN186315B (cs) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
ES2129010B1 (es) * 1997-01-02 2000-01-16 Gold Oscar Composicion de accion prolongada en granulos que contienen 4-nitro-2- fenoximetansulfonanilida y su procedimiento de preparacion.
IT1291895B1 (it) 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
IT1298221B1 (it) * 1998-02-10 1999-12-20 Helsinn Healthcare Sa Sali micronizzati di nimesulide
EP1218889B1 (en) * 1999-09-28 2009-12-02 Panacea Biotec Limited Controlled release compositions comprising nimesulide
IT1318588B1 (it) * 2000-06-20 2003-08-27 Helsinn Healthcare Sa Uso della nimesulide nel trattamento di patologie dermatologiche.
EP1172101A1 (en) * 2000-06-20 2002-01-16 Helsinn Healthcare S.A. The use of nimesulide for the treatment of psoriasis and psoriatic arthritis
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
PT1534340E (pt) 2002-09-06 2012-03-13 Cerulean Pharma Inc Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente
CA2501132A1 (en) 2002-10-09 2004-04-22 Insert Therapeutics, Inc. Cyclodextrin-based materials, compositions and uses related thereto
CN1511828A (zh) * 2002-12-31 2004-07-14 �й������ž�����ҽѧ��ѧԺ����ҽ 磺酰苯胺类衍生物及其医药用途
DE102004060914A1 (de) * 2004-12-17 2006-07-06 Bioghurt Biogarde Gmbh & Co. Kg Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
RU2363473C1 (ru) * 2008-02-18 2009-08-10 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ антифлогистической активации в эксперименте
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN109608370A (zh) * 2019-01-22 2019-04-12 山西康斯亚森生物科技有限公司 尼美舒利衍生物和制备方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
SU1513880A1 (ru) * 1987-12-21 1991-05-07 Inst Khim Bashkirskogo Nauchno Tpиc(диизoпpoпokcи)aлюmиhиebaя coль глициppизиhoboй kиcлotы, пpoяbляющaя пpotиbobocпaлиteльhую и пpotиboязbehhую aktиbhoctь
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1248475B (it) * 1990-05-22 1995-01-19 Angeli Inst Spa Composti di inclusione di nimesulide con ciclodestrine
WO1997017774A1 (en) * 1995-11-07 1997-05-15 Seiko Communications Systems, Inc. Selective advertisement presentation

Also Published As

Publication number Publication date
ES2124893T3 (es) 1999-02-16
DE69412760D1 (de) 1998-10-01
FI950294A7 (fi) 1995-01-24
NO950243L (no) 1995-03-13
EP0656015A1 (en) 1995-06-07
CA2140887A1 (en) 1994-12-08
RU2129564C1 (ru) 1999-04-27
EP0656015B1 (en) 1998-08-26
AU675146B2 (en) 1997-01-23
HUT68239A (en) 1995-06-28
ATE170194T1 (de) 1998-09-15
FI950294A0 (fi) 1995-01-24
WO1994028031A1 (en) 1994-12-08
CZ285962B6 (cs) 1999-12-15
AU7081394A (en) 1994-12-20
KR950702580A (ko) 1995-07-29
DE69412760T2 (de) 1999-05-20
JPH07509498A (ja) 1995-10-19
HU9301518D0 (en) 1993-09-28
CA2140887C (en) 2000-08-01
RU95105977A (ru) 1997-02-10
CZ16395A3 (en) 1995-10-18
NO307570B1 (no) 2000-04-25
SI0656015T1 (en) 1999-02-28
US5744165A (en) 1998-04-28
NO950243D0 (no) 1995-01-23
HU210922B (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DK0656015T3 (da) Nye inklusionskomplekser af nimesulidsalt med cyclodextrin
YU49312B (sh) Kristalni hidratni derivati 3,4,4-trisupstituisanih - peperidinil-n-alkilkarboksilata, njihovi intermedijari i postupak za dobijanje
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
BR9608041B8 (pt) Oligossacarídeo sulfatado, e, composição farmacêutica ou veterinária para tratamento anti-angiogênico, anti-metastático e/ou anti-inflamatório.
DK41193D0 (da) Ionkanalaabnere
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
ATE181551T1 (de) Taxol-derivate
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
GR3033827T3 (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DK0677046T3 (da) Piperazinderivater som 5-HT-antagonister.
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
PT96849A (pt) Processo de preparacao de novos derivados da beta-fenil-iso-serina e de beta-fenil-iso-serina-(2r,2s)
MXPA03008248A (es) Agentes colorantes para fibras de queratina que contienen derivados de n-heteroarilmetil-m-fenilendiamina, asi como nuevos derivados de n-heteroarilmetil-m-fenilendiamina.
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
NO954316D0 (no) Benzo(f)kinoksalidinonderivater, deres fremstilling og anvendelse i legemidler
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten